ACRO BIOMEDICAL CO., LTD.
ACBM · OTCMCIK 1622996fmd_1DVP7ZXHYH4EGMM3FKYPRQHNR9Services · Services-Amusement & Recreation ServicesTemplate: Standard
Coverage: Oct 01, 2014 to Jun 30, 2026, 46 periods
Latest annual · FY2025
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (0)
- Net income
- (0)
Latest quarter · Q2 FY2026
Millions- Total revenues
- 0
- Operating income
- (0)
- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- n/m
- Revenue, 5 yearsFY2020 to FY2025
- n/m
- Net income, 5 yearsFY2020 to FY2025
- n/m
ACRO BIOMEDICAL CO., LTD. (ACBM) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $0 | 10-K 2026-02-11 · proof | |
| Operating income | -$154,024 | -$37,958 | 10-K 2026-02-11 · proof | |
| Net income | -$101,146 | -$42,297 | 10-K 2026-02-11 · proof | |
| Cash from operating activities | -$196,302 | -$36,692 | 10-K 2026-02-11 · proof | |
| Total assets | $14,098 | $31,974 | -55.9% | 10-K 2026-02-11 · proof |
| Total liabilities | $401,062 | $326,946 | +22.7% | 10-K 2026-02-11 · proof |
| Cash and cash equivalents | $4,098 | $476 | +760.9% | 10-K 2026-02-11 · proof |
- What was ACRO BIOMEDICAL CO., LTD. (ACBM)'s revenue in fiscal 2025?
- ACRO BIOMEDICAL CO., LTD. (ACBM) reported revenue of $0 for fiscal 2025 (the year ended Dec 31, 2025), against $0 the year before. Source: the 10-K filed with the SEC on Feb 11, 2026. SEC
- What was ACRO BIOMEDICAL CO., LTD. (ACBM)'s operating income in fiscal 2025?
- ACRO BIOMEDICAL CO., LTD. (ACBM) reported operating income of -$154,024 for fiscal 2025 (the year ended Dec 31, 2025), against -$37,958 the year before. Source: the 10-K filed with the SEC on Feb 11, 2026. SEC
- What was ACRO BIOMEDICAL CO., LTD. (ACBM)'s net income in fiscal 2025?
- ACRO BIOMEDICAL CO., LTD. (ACBM) reported net income of -$101,146 for fiscal 2025 (the year ended Dec 31, 2025), against -$42,297 the year before. Source: the 10-K filed with the SEC on Feb 11, 2026. SEC
- What was ACRO BIOMEDICAL CO., LTD. (ACBM)'s cash from operating activities in fiscal 2025?
- ACRO BIOMEDICAL CO., LTD. (ACBM) reported cash from operating activities of -$196,302 for fiscal 2025 (the year ended Dec 31, 2025), against -$36,692 the year before. Source: the 10-K filed with the SEC on Feb 11, 2026. SEC
- What are ACRO BIOMEDICAL CO., LTD. (ACBM)'s total assets?
- As of Dec 31, 2025, ACRO BIOMEDICAL CO., LTD. (ACBM) reported total assets of $14,098, against $31,974 a year earlier (-55.9%). Source: the 10-K filed with the SEC on Feb 11, 2026. SEC
- What are ACRO BIOMEDICAL CO., LTD. (ACBM)'s total liabilities?
- As of Dec 31, 2025, ACRO BIOMEDICAL CO., LTD. (ACBM) reported total liabilities of $401,062, against $326,946 a year earlier (+22.7%). Source: the 10-K filed with the SEC on Feb 11, 2026. SEC
- What are ACRO BIOMEDICAL CO., LTD. (ACBM)'s cash and cash equivalents?
- As of Dec 31, 2025, ACRO BIOMEDICAL CO., LTD. (ACBM) reported cash and cash equivalents of $4,098, against $476 a year earlier (+760.9%). Source: the 10-K filed with the SEC on Feb 11, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:ACBM&period_type=annual&limit=5"Information only, not investment advice.